SCHEMBL4477440

SCHEMBL4477440

COc1cc(C=CC=C(C#N)C(=O)NCc2ccccc2)ccc1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.77
MCL1 Q07820 1/20 0.67
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
MAPT P10636 5/20 0.58
ALDH1A1 P00352 3/20 0.58
LMNA P02545 3/20 0.58
KDM4E B2RXH2 2/20 0.58
EEF2K O00418 1/20 0.58
PLK4 O00444 1/20 0.58
PIM1 P11309 1/20 0.58
AXL P30530 1/20 0.58
MAPKAPK2 P49137 1/20 0.58
GSK3A P49840 1/20 0.58
GSK3B P49841 1/20 0.58
IRAK1 P51617 1/20 0.58
PLK1 P53350 1/20 0.58
MAP4K2 Q12851 1/20 0.58
PRKAA1 Q13131 1/20 0.58
MARK2 Q7KZI7 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4477433 1.00 MAOB (0.77) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL3436925 0.96 MAOB (0.71) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL4484519 0.92 MAOB (0.70) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL4484514 0.92 MAOB (0.70) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL13678149 0.91 MAOB (0.64) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL13678107 0.91 MAOB (0.64) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL13678101 0.90 MAOB (0.78) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL4475751 0.90 MAOB (0.68) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL4475745 0.90 MAOB (0.68) MAOBMCL1MEN1KMT2AMAPT
SCHEMBL4489692 0.90 MCL1 (0.70) MAOBMCL1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed
US-20050014690-A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis THE HOSPITAL FOR SICK CHILDREN (CA) 2005-01-20 US disclosed
EP-1453500-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2004-09-08 EP disclosed
WO-2003030895-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAOB 3511/4885MCL1 7/4885MEN1 2749/4885
US-20050014690-A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis MCL1, MYD88, MYADM MAOB 3016/4885MCL1 1/4885MEN1 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.